FDA Asks Pfizer For More Data On Anti-Smoking Drug
The U.S Food and Drug Administration said it had received reports of suicidal thoughts and erratic behavior in smokers taking Pfizer Inc's anti-smoking drug Chantix and has asked the pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article